The forecasted R&D budget for health and medical sciences in Japan shows a steady increase from 2024 to 2028, with figures rising annually from $4.86 billion to $5.24 billion in PPP terms. This signifies a consistent year-on-year growth varying from approximately 1.85% to 2.02%. Looking back, assuming the budget in 2023 was similar to the starting budget in the forecast, the compound annual growth rate (CAGR) from 2023 to 2028 is estimated at around 1.9%.
Trends to watch for include Japan's potential focus on innovative healthcare technologies and demographic shifts, which may necessitate leadership in medical advancements and further drive funding increases.
